SEC Filings for Actinium Pharmaceuticals Inc. (Delaware) (ATNM)

$ 0.18   -0.006657 (-3.57%) Volume: 556.65k 8:00 PM EDT Apr 2, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities107/16/2019
4Statement of changes in beneficial ownership of securities107/16/2019
4Statement of changes in beneficial ownership of securities107/16/2019
4Statement of changes in beneficial ownership of securities107/16/2019
4Statement of changes in beneficial ownership of securities107/16/2019
8-KCurrent report pursuant to Section 13 or 15(d)306/07/2019
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans1005/10/2019
10-QGeneral form for quarterly reports under Section 13 or 15(d)4405/10/2019
8-KCurrent report pursuant to Section 13 or 15(d)7504/18/2019
424B5Prospectus [Rule 424(b)(5)]96704/18/2019
SC 13GStatement of acquisition of beneficial ownership by individuals104/18/2019
424B5Prospectus [Rule 424(b)(5)]94004/17/2019
10-KAnnual report pursuant to Section 13 or 15(d)15803/15/2019
8-KCurrent report pursuant to Section 13 or 15(d)303/12/2019
4Statement of changes in beneficial ownership of securities103/07/2019
123456789101112131415